首页> 美国卫生研究院文献>PLoS Clinical Trials >MDA-7/IL-24 Induces Bcl-2 Denitrosylation and Ubiquitin-Degradation Involved in Cancer Cell Apoptosis
【2h】

MDA-7/IL-24 Induces Bcl-2 Denitrosylation and Ubiquitin-Degradation Involved in Cancer Cell Apoptosis

机译:MDA-7 / IL-24诱导参与癌细胞凋亡的Bcl-2去亚硝基化和泛素降解

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

MDA-7/IL-24 was involved in the specific cancer apoptosis through suppression of Bcl-2 expression, which is a key apoptosis regulatory protein of the mitochondrial death pathway. However, the underlying mechanisms of this regulation are unclear. We report here that tumor-selective replicating adenovirus ZD55-IL-24 leads to Bcl-2 S-denitrosylation and concomitant ubiquitination, which take part in the 26S proteasome degradation. IL-24-siRNA completely blocks Bcl-2 ubiquitination via reversion of Bcl-2 S-denitrosylation and protects it from proteasomal degradation which confirmed the significant role of MDA-7/IL-24 in regulating posttranslational modification of Bcl-2 in cancer cells. Nitric oxide (NO) is a key regulator of protein S-nitrosylation and denitrosylation. The NO donor, sodium nitroprusside (SNP), down-regulates Bcl-2 S-denitrosylation, attenuates Bcl-2 ubiquitination and subsequently counteracts MDA-7/IL-24 induced cancer cell apoptosis, whereas NO inhibitor 2-(4-carboxyphenyl)-4,4,5,5-tetramethylimidazoline-1-oxy-3-oxide (PTIO) shows the opposite effect. At the same time, these NO modulators fail to affect Bcl-2 phosphorylation, suggesting that NO regulates Bcl-2 stability in a phosphorylation-independent manner. In addition, Bcl-2 S-nitrosylation reduction induced by ZD55-IL-24 was attributed to both iNOS decrease and TrxR1 increase. iNOS-siRNA facilitates Bcl-2 S-denitrosylation and ubiquitin-degradation, whereas the TrxR1 inhibitor auranofin prevents Bcl-2 from denitrosylation and ubiquitination, thus restrains the caspase signal pathway activation and subsequent cancer cell apoptosis. Taken together, our studies reveal that MDA-7/IL-24 induces Bcl-2 S-denitrosylation via regulation of iNOS and TrxR1. Moreover, denitrosylation of Bcl-2 results in its ubiquitination and subsequent caspase protease family activation, as a consequence, apoptosis susceptibility. These findings provide a novel insight into MDA-7/IL-24 induced growth inhibition and carcinoma apoptosis.
机译:MDA-7 / IL-24通过抑制Bcl-2表达参与特定的癌症凋亡,而Bcl-2表达是线粒体死亡途径的关键凋亡调控蛋白。但是,该法规的潜在机制尚不清楚。我们在这里报告肿瘤选择性复制腺病毒ZD55-IL-24导致Bcl-2 S-去亚硝基化和伴随的泛素化,参与26S蛋白酶体降解。 IL-24-siRNA通过逆转Bcl-2 S-去亚硝基化而完全阻断Bcl-2泛素化,并保护其免受蛋白酶体降解,这证实了MDA-7 / IL-24在调节癌细胞中Bcl-2的翻译后修饰中的重要作用。一氧化氮(NO)是蛋白质S-亚硝基化和脱亚硝基化的关键调节剂。 NO供体硝普钠(SNP)下调Bcl-2 S-去亚硝基化,减弱Bcl-2泛素化并随后抵消MDA-7 / IL-24诱导的癌细胞凋亡,而NO抑制剂2-(4-羧基苯基) -4,4,5,5-四甲基咪唑啉-1-氧-3-氧化物(PTIO)显示相反的作用。同时,这些NO调节剂不能影响Bcl-2的磷酸化,表明NO以磷酸化非依赖性的方式调节Bcl-2的稳定性。此外,ZD55-IL-24诱导的Bcl-2 S亚硝基化的减少归因于iNOS的减少和TrxR1的增加。 iNOS-siRNA促进Bcl-2 S-去亚硝化和泛素降解,而TrxR1抑制剂金诺芬可防止Bcl-2脱亚硝化和泛素化,从而抑制caspase信号通路的激活和随后的癌细胞凋亡。两者合计,我们的研究表明,MDA-7 / IL-24通过调节iNOS和TrxR1诱导Bcl-2 S-亚硝基化。此外,Bcl-2的亚硝基化会导致其泛素化和随后的半胱天冬酶蛋白酶家族的活化,从而导致细胞凋亡的敏感性。这些发现为MDA-7 / IL-24诱导的生长抑制和癌细胞凋亡提供了新颖的见解。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号